News
Survival ‘excellent’ after rituximab-bendamustine induction in transplant-eligible MCL
Investigators reported that the regimen’s efficacy is on par with R-hyperCVAD, but is less toxic.
News
Inhaled nitric oxide improves activity in pulmonary fibrosis patients at risk of PH
Longer-term data suggest a maintenance of effect in patients who continued on an open-label extension.
News
Emicizumab effective in children with hemophilia A and inhibitors
Emicizumab stands to become the “next-generation standard of care” for these pediatric patients, report says.
News
Virtual visits may cut no-show rate for follow-up HF appointment
PHILADELPHIA – .
News
Patients have good recall on lung cancer screening scan benefits, not risks
NEW ORLEANS – Results suggest need for ongoing patient education beyond the initial shared decision-making encounter.
News
Readmission for COPD exacerbation upped in-hospital mortality risk
NEW ORLEANS – Reduction of readmission rates has potential to improve health and economic outcomes, according to researchers.
News
Next-gen genomic test plus bronchoscopy may improve lung nodule management
NEW ORLEANS – The test is seen as complementary to bronchoscopy, improving the sensitivity of bronchoscopy.
News
Vitamin C–based regimens in sepsis plausible, need more data, expert says
NEW ORLEANS – Results from the randomized, phase 3 VICTAS study, anticipated in the coming months, may shed light on...
News
Recent COPD exacerbation did not affect aclidinium’s efficacy in high-risk patients
NEW ORLEANS – A history of recent exacerbations didn’t significantly affect the safety or efficacy of aclidinium bromide in patients with moderate...
News
In-hospital flu shot reduced readmissions in pneumonia patients
NEW ORLEANS – ...
News
Early palliative care consult decreases in-hospital mortality
NEW ORLEANS – More discharges to hospice, and more health care surrogates chosen, when palliative care consultation occurs within 24 hours of ICU...
News
Race mismatch may affect survival in lung transplant setting
NEW ORLEANS – If it’s an option, clinicians should consider donor-to-recipient race compatibility.
News
Patiromer allows more CKD patients to continue on spironolactone
PHILADELPHIA – After 12 weeks, 86% of the patiromer patients remained on spironolactone, vs. 66% of the placebo patients.
News
Checklist may improve quality measures in the surgical ICU
NEW ORLEANS – Length of stay, number of ventilator days both reduced with use of the standardized instrument.
News
Low disease activity a valid target in early SLE, investigators say
Both lupus low disease activity state and complete remission by 6 months translated into less damage at 18 months in retrospective analysis.